# | Title | Journal | Year | Citations |
---|
1 | Extracorporeal Endotoxin Removal For The Treatment of Sepsis:Endotoxin Adsorption Cartridge (Toraymyxin) | Therapeutic Apheresis and Dialysis | 2003 | 703 |
2 | Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder | Therapeutic Apheresis and Dialysis | 2013 | 305 |
3 | An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013) | Therapeutic Apheresis and Dialysis | 2015 | 275 |
4 | Adacolumn, an Adsorptive Carrier Based Granulocyte and MonocyteApheresis Device for the Treatment of Inflammatory and RefractoryDiseases Associated with Leukocytes | Therapeutic Apheresis and Dialysis | 2003 | 234 |
5 | 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease | Therapeutic Apheresis and Dialysis | 2010 | 211 |
6 | Clinical Practice Guideline for the Management of Secondary Hyperparathyroidism in Chronic Dialysis Patients | Therapeutic Apheresis and Dialysis | 2008 | 164 |
7 | Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008) | Therapeutic Apheresis and Dialysis | 2010 | 151 |
8 | Long-term Effect of Low-density Lipoprotein Apheresis in Patients with Homozygous Familial Hypercholesterolemia | Therapeutic Apheresis and Dialysis | 2003 | 149 |
9 | 2011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis | Therapeutic Apheresis and Dialysis | 2015 | 139 |
10 | Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients | Therapeutic Apheresis and Dialysis | 2013 | 133 |
11 | Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011) | Therapeutic Apheresis and Dialysis | 2013 | 132 |
12 | Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients | Therapeutic Apheresis and Dialysis | 2005 | 131 |
13 | Complications of Therapeutic Plasma Exchange: Experience With 4857 Treatments | Therapeutic Apheresis and Dialysis | 2005 | 129 |
14 | Extracorporeal Photochemotherapy for the Treatment of Graft‐Versus‐Host Disease | Therapeutic Apheresis and Dialysis | 2002 | 117 |
15 | An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012) | Therapeutic Apheresis and Dialysis | 2014 | 115 |
16 | Inhibition of Intestinal Sodium‐dependent Inorganic Phosphate Transport by Fibroblast Growth Factor 23 | Therapeutic Apheresis and Dialysis | 2005 | 114 |
17 | Drug-induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Concise Review | Therapeutic Apheresis and Dialysis | 2004 | 112 |
18 | An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010) | Therapeutic Apheresis and Dialysis | 2012 | 111 |
19 | Improvement of Multiple Organ Functions in Hepatorenal Syndrome During Albumin Dialysis with the Molecular Adsorbent Recirculating System | Therapeutic Apheresis and Dialysis | 2001 | 109 |
20 | Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis | Therapeutic Apheresis and Dialysis | 2012 | 109 |
21 | Studies on the Mechanisms of Leukocyte Adhesion to Cellulose Acetate Beads: An In Vitro Model to Assess the Efficacy of Cellulose Acetate Carrier‐based Granulocyte and Monocyte Adsorptive Apheresis | Therapeutic Apheresis and Dialysis | 2003 | 107 |
22 | 2005 Japanese Society for Dialysis Therapy Guidelines for Vascular Access Construction and Repair for Chronic Hemodialysis | Therapeutic Apheresis and Dialysis | 2006 | 104 |
23 | Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST‐120 | Therapeutic Apheresis and Dialysis | 2011 | 99 |
24 | Atypical Hemolytic‐Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment | Therapeutic Apheresis and Dialysis | 2019 | 95 |
25 | An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2007) | Therapeutic Apheresis and Dialysis | 2009 | 90 |
26 | Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan | Therapeutic Apheresis and Dialysis | 2008 | 88 |
27 | Severe Hypertriglyceridemia‐Related Acute Pancreatitis | Therapeutic Apheresis and Dialysis | 2013 | 88 |
28 | Japanese Society for Dialysis Therapy Clinical Guideline for “Maintenance Hemodialysis: Hemodialysis Prescriptions” | Therapeutic Apheresis and Dialysis | 2015 | 88 |
29 | Role of Plasma Exchange in the Thyroid Storm | Therapeutic Apheresis and Dialysis | 2011 | 85 |
30 | In Vitro Evaluation of High Mobility Group Box 1 Protein Removal with Various Membranes for Continuous Hemofiltration | Therapeutic Apheresis and Dialysis | 2011 | 84 |
31 | Overview of Regular Dialysis Treatment in Japan (as of 31 December 2009) | Therapeutic Apheresis and Dialysis | 2012 | 83 |
32 | Standard on Microbiological Management of Fluids for Hemodialysis and Related Therapies by the Japanese Society for Dialysis Therapy 2008 | Therapeutic Apheresis and Dialysis | 2009 | 81 |
33 | Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study | Therapeutic Apheresis and Dialysis | 2020 | 81 |
34 | The Role of Plasmapheresis in the Treatment of Severe Central Nervous System Neuropsychiatric Systemic Lupus Erythematosus | Therapeutic Apheresis and Dialysis | 2003 | 80 |
35 | Intermittent Plasmapheresis Prevents Recurrence in Neuromyelitis Optica | Therapeutic Apheresis and Dialysis | 2009 | 78 |
36 | Therapeutic Apheresis-State of the Art in the Year 2005 | Therapeutic Apheresis and Dialysis | 2005 | 76 |
37 | Plasmapheresis in Thrombotic Microangiopathy-Associated Syndromes: Review of Outcome Data Derived from Clinical Trials and Open Studies | Therapeutic Apheresis and Dialysis | 2002 | 75 |
38 | Prevention of Limb Amputation in Patients with Limbs Ulcers by Autologous Peripheral Blood Mononuclear Cell Implantation | Therapeutic Apheresis and Dialysis | 2005 | 75 |
39 | Removal of Humoral Mediators and the Effect on the Survival of Septic Patients by Hemoperfusion With Neutral Microporous Resin Column | Therapeutic Apheresis and Dialysis | 2010 | 75 |
40 | Role of Oxidative Stress and Indoxyl Sulfate in Progression of Cardiovascular Disease in Chronic Kidney Disease | Therapeutic Apheresis and Dialysis | 2011 | 75 |
41 | Low-density Lipoprotein Apheresis: An Overview | Therapeutic Apheresis and Dialysis | 2003 | 73 |
42 | AST-120, an Oral Adsorbent, Delays the Initiation of Dialysis in Patients With Chronic Kidney Diseases | Therapeutic Apheresis and Dialysis | 2007 | 72 |
43 | Current Topics on Cytokine Removal Technologies | Therapeutic Apheresis and Dialysis | 2001 | 71 |
44 | Management of Intra-abdominal Hypertension in Patients With Severe Acute Pancreatitis With Continuous Hemodiafiltration Using a Polymethyl Methacrylate Membrane Hemofilter | Therapeutic Apheresis and Dialysis | 2005 | 71 |
45 | 2004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients* | Therapeutic Apheresis and Dialysis | 2004 | 67 |
46 | Zinc Deficiency Anemia and Effects of Zinc Therapy in Maintenance Hemodialysis Patients | Therapeutic Apheresis and Dialysis | 2009 | 67 |
47 | Plasma Exchange in Patients with Toxic Epidermal Necrolysis | Therapeutic Apheresis and Dialysis | 2002 | 66 |
48 | Lanthanum Carbonate Effectively Controls Serum Phosphate Without Affecting Serum Calcium Levels in Patients Undergoing Hemodialysis | Therapeutic Apheresis and Dialysis | 2008 | 66 |
49 | Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study | Therapeutic Apheresis and Dialysis | 2010 | 66 |
50 | Best Practice for Diabetic Patients on Hemodialysis 2012 | Therapeutic Apheresis and Dialysis | 2015 | 64 |